Can you provide a patient letter outlining the evaluation steps for excessive daytime sleepiness before initiating lisdexamfetamine (Vyvanse)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Patient Evaluation Letter for Excessive Daytime Sleepiness Prior to Lisdexamfetamine (Vyvanse) Initiation

Dear Patient,

Before we can consider starting lisdexamfetamine (Vyvanse) for your excessive daytime sleepiness, we must complete a comprehensive evaluation to identify and address the underlying cause of your sleepiness, as stimulant medications are only appropriate after ruling out or optimally treating other conditions 1.

Required Evaluation Steps

1. Medical History and Assessment

You will need to provide detailed information about:

  • Sleep patterns: How many hours do you sleep at night? Is your nighttime sleep disrupted? Do you have adequate opportunity for sleep (at least 7-9 hours in bed)?
  • Daytime symptoms: When did the sleepiness start? How often does it occur? Do short naps (15-20 minutes) help?
  • Associated symptoms: Do you experience sudden muscle weakness with emotions (cataplexy), vivid dreams at sleep onset, inability to move when falling asleep or waking up, or witnessed breathing pauses during sleep?
  • Current medications: All prescription drugs, over-the-counter medications, and supplements you take, as many can cause sleepiness 1
  • Medical conditions: Thyroid problems, heart disease, neurological conditions, depression, anxiety, or other psychiatric disorders 1
  • Substance use: Alcohol consumption, caffeine intake, and any recreational drug use

2. Physical Examination

Your provider will perform:

  • Cardiac assessment including blood pressure and heart rate
  • Neurological examination
  • Cognitive assessment
  • Evaluation for signs of other medical conditions that cause sleepiness 1

3. Questionnaires

You will complete the Epworth Sleepiness Scale (ESS), which helps quantify your level of daytime sleepiness 1.

4. Sleep Studies

Most patients require objective sleep testing 1:

  • Overnight polysomnography (sleep study): This monitors your sleep overnight to detect sleep apnea, periodic limb movements, and other sleep disorders that must be treated first
  • Multiple Sleep Latency Test (MSLT): Performed the day after the overnight study, this involves 4-5 scheduled nap opportunities to measure how quickly you fall asleep and whether you enter REM sleep abnormally early (which suggests narcolepsy) 1

5. Laboratory Tests

Blood work will be ordered to check for medical causes of sleepiness 1:

  • Thyroid function (TSH)
  • Complete blood count
  • Liver function tests
  • Kidney function
  • Other tests as clinically indicated

Why This Evaluation Is Necessary

Stimulant medications like lisdexamfetamine are not first-line treatment for excessive daytime sleepiness 1. They are only considered after:

  1. Excluding sleep deprivation: Ensuring you have adequate opportunity for nighttime sleep
  2. Treating primary sleep disorders: If you have sleep apnea, it must be adequately treated with CPAP, oral appliances, or surgery first 1
  3. Optimizing medical conditions: Any underlying medical, neurological, or psychiatric disorders must be addressed 1
  4. Reviewing medications: Sedating medications should be reduced or discontinued if possible 1

When Lisdexamfetamine May Be Appropriate

Lisdexamfetamine may be considered if you have 1, 2:

  • Confirmed narcolepsy (with or without cataplexy) based on sleep study results
  • Residual excessive sleepiness despite optimal treatment of sleep apnea or other sleep disorders
  • No contraindications such as significant heart disease, uncontrolled high blood pressure, history of drug abuse, or certain psychiatric conditions

Important Safety Considerations

Before starting lisdexamfetamine, we must assess 2:

  • Your cardiac health and family history of sudden death or heart rhythm problems
  • History of tics or Tourette's syndrome
  • Kidney function (dose adjustments needed if impaired)
  • Current medications that may interact

Next Steps

Please schedule the following appointments:

  1. Initial consultation with sleep medicine specialist
  2. Overnight sleep study (polysomnography)
  3. Multiple Sleep Latency Test (if indicated)
  4. Follow-up appointment to review results and discuss treatment options

Only after completing this evaluation can we determine if lisdexamfetamine is appropriate and safe for you. In many cases, treating the underlying cause of sleepiness (such as sleep apnea or insufficient sleep) combined with behavioral modifications (regular sleep schedule, strategic napping, good sleep hygiene) may adequately address your symptoms without needing stimulant medication 1.

Please contact our office to schedule your evaluation appointments.

Sincerely,

[Provider Name]

Related Questions

What therapy options can improve alertness in a patient who is adherent to CPAP therapy but continues to have excessive daytime sleepiness?
In a patient with obstructive sleep apnea who is adherent to CPAP with adequate usage and low residual AHI but continues to have excessive daytime somnolence, what are the next steps in evaluation and management?
A 28-year-old man has persistent daytime sleepiness and low energy despite adequate nighttime sleep, and has tried sertraline (Zoloft) and bupropion without improvement; what initial evaluation and management steps should be taken?
What is the recommended treatment for a 61-year-old woman with multiple sclerosis (MS) and excessive daytime sleepiness (EDS) despite adequate nighttime sleep, with no sleep-disordered breathing?
What are the non‑organic causes of excessive afternoon sleepiness and how can it be managed with evidence‑based lifestyle interventions and reliable resources?
What are the interactions between Adderall (mixed amphetamine salts) and Thorazine (chlorpromazine)?
Can acute volume overload in the first 24 hours after cardiac surgery precipitate right‑ventricular failure in a patient without pre‑operative RV dysfunction?
What are the NCCN guidelines for the management of metastatic breast cancer, including hormone‑receptor‑positive/HER2‑negative, HER2‑positive, and triple‑negative subtypes?
What is the recommended management plan for opioid use disorder?
What are the symptoms of optic floaters?
What are the recommended starting and maintenance doses for buprenorphine, methadone, and oral naltrexone in the treatment of opioid use disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.